Insights

Consistent Revenue Growth Recordati reported solid financial performance in the first nine months of 2025, with revenue increasing by 12.2% and EBITDA by 11.8%, indicating a strong market presence and potential for expanding sales in existing and new markets.

Successful Rare Disease Portfolio The company's flagship product, Isturisa, achieved sales estimates exceeding €1.2 billion, doubling previous expectations, reflecting a substantial opportunity for targeted sales efforts in rare disease treatment markets.

Global Market Reach With operations across around 150 countries, Recordati offers extensive opportunities to develop regional sales strategies, especially in growth markets seeking innovative pharmaceuticals for common and rare conditions.

Innovative Growth Strategies Recordati's commitment to new ideas, technologies, and innovations to fight diseases presents opportunities for partnership in product development and the integration of advanced pharmaceutical solutions.

Stable Financial Foundation Despite high competition, Recordati's robust revenue and positive growth trajectory suggest potential for upselling and cross-selling existing product lines, especially targeting healthcare providers seeking high-quality medicines.

Recordati Tech Stack

Recordati uses 8 technology products and services including CookieYes, Oracle Argus, MasterControl, and more. Explore Recordati's tech stack below.

  • CookieYes
    Cookie Compliance
  • Oracle Argus
    Data Management
  • MasterControl
    Document Management Systems
  • Apple iCloud Mail
    Email
  • Google Fonts API
    Font Scripts
  • Windows Server
    Operating Systems
  • Bootstrap
    UI Frameworks
  • Piwik PRO Core
    Web Analytics

Recordati's Email Address Formats

Recordati uses at least 1 format(s):
Recordati Email FormatsExamplePercentage
Last.F@recordati.comDoe.J@recordati.com
67%
First.L@recordati.comJohn.D@recordati.com
27%
First.Last@recordati.comJohn.Doe@recordati.com
6%

Frequently Asked Questions

Where is Recordati's headquarters located?

Minus sign iconPlus sign icon
Recordati's main headquarters is located at Via Matteo Civitali, 1 Milan, Italy 20148 IT. The company has employees across 5 continents, including EuropeAsiaNorth America.

What is Recordati's stock symbol?

Minus sign iconPlus sign icon
Recordati is a publicly traded company; the company's stock symbol is REC.MI.

What is Recordati's official website and social media links?

Minus sign iconPlus sign icon
Recordati's official website is recordati.com and has social profiles on LinkedIn.

How much revenue does Recordati generate?

Minus sign iconPlus sign icon
As of October 2025, Recordati's annual revenue is estimated to be $5B.

What is Recordati's SIC code NAICS code?

Minus sign iconPlus sign icon
Recordati's SIC code is 8721 - Accounting, Auditing, and Bookkeeping Services NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Recordati have currently?

Minus sign iconPlus sign icon
As of October 2025, Recordati has approximately 4.1K employees across 5 continents, including EuropeAsiaNorth America. Key team members include Chief Executive Officer: R. K.Chief Executive Officer: A. R.Chief Medical Officer & Head Of Recordati Rare Diseases Foundation: R. S.. Explore Recordati's employee directory with LeadIQ.

What industry does Recordati belong to?

Minus sign iconPlus sign icon
Recordati operates in the Pharmaceutical Manufacturing industry.

What technology does Recordati use?

Minus sign iconPlus sign icon
Recordati's tech stack includes CookieYesOracle ArgusMasterControlApple iCloud MailGoogle Fonts APIWindows ServerBootstrapPiwik PRO Core.

What is Recordati's email format?

Minus sign iconPlus sign icon
Recordati's email format typically follows the pattern of Last.F@recordati.com. Find more Recordati email formats with LeadIQ.
Recordati

Recordati

Pharmaceutical ManufacturingItaly, Italy1001-5000 Employees

Recordati has been at the forefront of life-enhancing and life-changing medicines for almost 100 years.

With its beginnings in a family run pharmacy in Correggio, Italy in the 1920s, Recordati is now a global pharmaceutical force, listed on the Italian stock exchange, with over 4,300 employees.

We are a group of like-minded, passionate individuals who go to extraordinary lengths for our partners, customers, investors and the people across the globe who we serve. We develop and commercialise medicines to serve people living with common diseases, as well as those living with some of the rarest, in around 150 countries.

At Recordati, our mantra is simple. We’ve always believed that health, and the opportunity to live life to the fullest, is a right, not a privilege. Whether that is for common diseases or the rarest – we want to give people the opportunity to be the best version of themselves.

This drive will never stop. Together, we will always be reimagining tomorrow – with new ideas, new technologies and new innovations to fight diseases.

Recordati. Unlocking the full potential of life.

Section iconCompany Overview

Headquarters
Via Matteo Civitali, 1 Milan, Italy 20148 IT
SIC Code
8721 - Accounting, Auditing, and Bookkeeping Services
Stock Symbol
REC.MI
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
1001-5000

Section iconFunding & Financials

  • $1B$10B

    Recordati's revenue is estimated to be in the range of $1B$10B

Section iconFunding & Financials

  • $1B$10B

    Recordati's revenue is estimated to be in the range of $1B$10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.